Ovarian Neoplasms: all 2,757 studies
Page 9 of 28. Open to participants first (735), then studies with results posted, then the rest; newest registration first within each.
- Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid TumorsTerminatedNCT04234113Phase 1Results posted
- Phase 1/2a Study of SQ3370 in Patients With Advanced Solid TumorsTerminatedNCT04106492Phase 1/2Results posted
- Sacral Nerve Stimulation in Treating Low Anterior Resection Syndrome or Fecal Incontinence in Patients With Locally Advanced Rectal Cancer or Other Pelvic Cancer, the RESTORE StudyTerminatedNCT04066894Phase 2Results posted
- A Study of Serum Folate Levels in Patients Treated With OlaparibCompletedNCT04024254Phase 4Results posted
- AVB-S6-500 and Durvalumab in Treating Patients With Platinum-Resistant or Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal CancerTerminatedNCT04019288Phase 1/2Results posted
- Adapting Multiple Behavior Interventions That Effectively Improve Cancer Survivor Health Cancer Survivor HealthCompletedNCT04000880Not applicableResults posted
- Cancer Loyalty Card StudyCompletedNCT03994653Results posted
- Dose-Esc/Exp RMC4630 & Cobi in Relapsed/Refractory Solid Tumors & RMC4630& Osi in EGFR+ Locally Adv/Meta NSCLCCompletedNCT03989115Phase 1/2Results posted
- Study to Evaluate the Efficacy and Safety of the Combination of Niraparib and Dostarlimab (TSR-042) in Participants With Platinum Resistant Ovarian CancerTerminatedNCT03955471Phase 2Results posted
- Treatment Effects on Development of Chemotherapy-Induced Peripheral Neuropathy in Patients With CancerActive, not recruitingNCT03939481Results posted
- A Study Evaluating the Safety, Pharmacokinetics and Efficacy of Ipatasertib Administered in Combination With Rucaparib in Participants With Advanced Breast, Ovarian Cancer, and Prostate Cancer.CompletedNCT03840200Phase 1Results posted
- A Trial Evaluating TG4050 in Ovarian Carcinoma.CompletedNCT03839524Phase 1Results posted
- Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) in Previously Treated Participants With Select Solid Tumors (MK-7902-005/E7080-G000-224/LEAP-005)CompletedNCT03797326Phase 2Results posted
- European Trial on Enhanced DNA Repair Inhibition in Ovarian CancerCompletedNCT03783949Phase 2Results posted
- Study of Relacorilant in Combination With Nab-Paclitaxel for Patients With Recurrent Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal CancerCompletedNCT03776812Phase 2Results posted
- Acupressure for Fatigue in Ovarian Cancer SurvivorsCompletedNCT03763838Not applicableResults posted
- Japan Phase 2 Study of Niraparib in Participants With Advanced, Relapsed Ovarian CancerCompletedNCT03759600Phase 2Results posted
- Japan Phase 2 Study of Niraparib (Maintenance Therapy) in Participants With Relapsed Ovarian CancerCompletedNCT03759587Phase 2Results posted
- Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK-001/ENGOT-ov43/GOG-3036)CompletedNCT03740165Phase 3Results posted
- Durvalumab Treatment in Combination With Chemotherapy and Bevacizumab, Followed by Maintenance Durvalumab, Bevacizumab and Olaparib Treatment in Advanced Ovarian Cancer PatientsActive, not recruitingNCT03737643Phase 3Results posted
- Phase Ib/II Study of Carboplatin + M6620 + Avelumab in PARPi-resistant Ovarian CancerCompletedNCT03704467Phase 1Results posted
- Supportive Programs for Supporting Optimal Recovery in Participants Undergoing Gynecological SurgeryCompletedNCT03681405Not applicableResults posted
- A Study of Weekly Tisotumab Vedotin for Patients With Platinum-Resistant Ovarian Cancer With Safety Run-in (innovaTV 208)CompletedNCT03657043Phase 2Results posted
- Avelumab and Talazoparib in Untreated Advanced Ovarian Cancer (JAVELIN OVARIAN PARP 100)TerminatedNCT03642132Phase 3Results posted
- The Effects of Exercise on Distress, Quality of Life, and Biomarkers in Ovarian Cancer SurvivorsTerminatedNCT03641287Not applicableResults posted
- Autologous Tumor Infiltrating Lymphocytes MDA-TIL in Treating Patients With Recurrent or Refractory Ovarian Cancer, Colorectal Cancer, or Pancreatic Ductal AdenocarcinomaTerminatedNCT03610490Phase 2Results posted
- Lavage of the Uterine Cavity for Diagnosis of Ovarian CancerTerminatedNCT03606486Not applicableResults posted
- A Comparison of Platinum-based Therapy With TSR-042 and Niraparib Versus Standard of Care (SOC) Platinum-based Therapy as First-line Treatment of Stage III or IV Nonmucinous Epithelial Ovarian CancerActive, not recruitingNCT03602859Phase 3Results posted
- Compare Fallopian Tube Cells Collected by Cytuity With Removed Ovarian/Tubal Tissue to Determine Presence of MalignancyCompletedNCT03593681Results posted
- A Study to Evaluate the Efficacy and Safety of Novel Treatment Combinations in Participants With Ovarian CancerCompletedNCT03574779Phase 2Results posted
- Study of Magrolimab (Hu5F9-G4) in Combination With Avelumab in Solid Tumor Participants and Checkpoint-Inhibitor-Naive Ovarian Cancer Participants Who Progress Within 6 Months of Prior Platinum ChemotherapyCompletedNCT03558139Phase 1Results posted
- Pilot Study of Rosuvastatin and Enoxaparin Thromboprophylaxis Following Ovarian Cancer Surgery (O-STAT Study)CompletedNCT03532139Phase 2Results posted
- A Study of PF-06873600 in People With CancerTerminatedNCT03519178Phase 1/2Results posted
- Trial of Trientine Plus Pegylated Liposomal Doxorubicin and Carboplatin in Epithelial Ovarian CancerCompletedNCT03480750Phase 1/2Results posted
- Trial of Pembrolizumab Following Weekly Paclitaxel for Platinum-resistant Ovarian, Fallopian Tube or Peritoneal CancerCompletedNCT03430700Phase 2Results posted
- Pembrolizumab in Treating Participants With Metastatic, Recurrent or Locally Advanced Cancer and Genomic InstabilityActive, not recruitingNCT03428802Phase 2Results posted
- A Phase I Dose-escalation Study of Subcutaneous ALM201 in Patients With Advanced Ovarian Cancer and Other Solid TumoursTerminatedNCT03427073Phase 1Results posted
- A Study of Prexasertib (LY2606368) in Platinum-Resistant or Refractory Recurrent Ovarian CancerCompletedNCT03414047Phase 2Results posted
- Multicentre Study of Olaparib Maintenance Monotherapy in Platinum Sensitive Relapsed Non gBRCAm Ovarian Cancer PatientsCompletedNCT03402841Phase 3Results posted
- A Study of DKN-01 as a Monotherapy or in Combination With Paclitaxel in Patients With Recurrent Epithelial Endometrial or Epithelial Ovarian Cancer or CarcinosarcomaCompletedNCT03395080Phase 2Results posted
- Atezolizumab With Neoadjuvant Chemotherapy for Patients With Newly-Diagnosed Advanced-Stage Ovarian CancerCompletedNCT03394885Phase 1/2Results posted
- Pilot Study of Denosumab in BRCA1/2 Mutation Carriers Scheduled for Risk-Reducing Salpingo-OophorectomyTerminatedNCT03382574Early Phase 1Results posted
- EHealth Mindful Movement and Breathing in Improving Outcomes in Participants Undergoing Gynecologic SurgeryCompletedNCT03379376Not applicableResults posted
- BOLSTER: Building Out Lifelines for Safety, Trust, Empowerment and RenewalCompletedNCT03367247Not applicableResults posted
- Stepping Into Survivorship: Harnessing Behavioral Economics to Improve Quality of Life in Ovarian CancerCompletedNCT03364673Not applicableResults posted
- Pharmacokinetic and Safety Study of Niraparib With Normal or Moderate Hepatic Impairment PatientsCompletedNCT03359850Phase 1Results posted
- Tazemetostat in Treating Patients With Recurrent Ovarian or Endometrial CancerActive, not recruitingNCT03348631Phase 2Results posted
- Study of the Safety, Pharmacokinetics and Efficacy of Tinostamustine in Patients With Advanced Solid Tumors.CompletedNCT03345485Phase 1/2Results posted
- Genetic Risk Assessment for Cancer Education and Empowerment (GRACE) ProjectCompletedNCT03326713Not applicableResults posted
- A Study of Niraparib Combined With Bevacizumab Maintenance Treatment in Participants With Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based ChemotherapyCompletedNCT03326193Phase 2Results posted
- Dose Escalation and Efficacy Study of mRNA-2416 for Intratumoral Injection Alone and in Combination With Durvalumab for Participants With Advanced MalignanciesTerminatedNCT03323398Phase 1/2Results posted
- A Phase 1/2 Study of INCB001158 in Combination With Chemotherapy in Subjects With Solid TumorsCompletedNCT03314935Phase 1/2Results posted
- Best Approach in Recurrent-Ovarian-Cancer-with Cediranib-OlaparibCompletedNCT03314740Phase 2Results posted
- Anti-PD-L1 and SAbR for Ovarian CancerTerminatedNCT03312114Phase 2Results posted
- A Study of DSP-7888 Dosing Emulsion in Combination With Immune Checkpoint Inhibitors in Adult Patients With Advanced Solid TumorsTerminatedNCT03311334Phase 1/2Results posted
- PIPAC Nab-pac for Stomach, Pancreas, Breast and Ovarian CancerCompletedNCT03304210Phase 1Results posted
- TIL Therapy in Combination With Checkpoint Inhibitors for Metastatic Ovarian CancerCompletedNCT03287674Phase 1/2Results posted
- ROCKIF Trial: Re-sensitization of Carboplatin-resistant Ovarian Cancer With Kinase Inhibition of FAKTerminatedNCT03287271Phase 1/2Results posted
- p53 Activation in Platinum-Resistant High Grade Serous Ovarian Cancer, a Study of PLD With APR-246CompletedNCT03268382Phase 2Results posted
- Clinical Trial of Combined Fostamatinib and Paclitaxel in Ovarian CancerCompletedNCT03246074Phase 1Results posted
- Tisotumab Vedotin Continued Treatment in Patients With Solid Tumors.CompletedNCT03245736Phase 2Results posted
- Pembrolizumab (Anti-PD-1) and AMG386 (Angiopoietin-2 (Ang-2) in Patients With Advanced Solid TumorCompletedNCT03239145Phase 1Results posted
- Feasibility Study of New Method of Diagnostic and Prediction of Painful CIPNTerminatedNCT03206216Not applicableResults posted
- Atezolizumab, Guadecitabine, and CDX-1401 Vaccine in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal CancerTerminatedNCT03206047Phase 1/2Results posted
- Hyperthermic Intraperitoneal Chemotherapy Trial Comparing Quality of Life in Patients With Stage IIIC-IV Ovarian, Fallopian Tube, or Primary Peritoneal CancerCompletedNCT03188432Phase 2Results posted
- OTL38 for Intra-operative Imaging of Folate Receptor Positive Ovarian CancerCompletedNCT03180307Phase 3Results posted
- Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic CancerCompletedNCT03180294Phase 2Results posted
- QoL-Comparison Between Trabectedin/PLD and Pt-based Therapy in Patients With Pt-sensitive Recurrent Ovarian CancerTerminatedNCT03164980Phase 4Results posted
- Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With CancerCompletedNCT03154190Not applicableResults posted
- NUC-1031 in Patients With Platinum-Resistant Ovarian CancerTerminatedNCT03146663Phase 2Results posted
- MAGE-A4ᶜ¹º³²T for Multi-TumorActive, not recruitingNCT03132922Phase 1Results posted
- QUILT-3.040: ETBX-011 (Ad5 [E1-, E2b-]-CEA(6D)) Vaccine in Combination With ALT-803 (Super-agonist IL-15) in Subjects Having CEA-Expressing CancerTerminatedNCT03127098Phase 1/2Results posted
- Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of INCAGN01876 Combined With Immune Therapies in Advanced or Metastatic MalignanciesCompletedNCT03126110Phase 1/2Results posted
- A Study to Examine Olaparib Maintenance Retreatment in Patients With Epithelial Ovarian Cancer.CompletedNCT03106987Phase 3Results posted
- Metastatic Tumor Cell Trap Device in Patients With Advanced Ovarian CancerCompletedNCT03085238Not applicableResults posted
- Trabectedin Combined With Durvalumab in Patients With Advanced Pretreated Soft-tissue Sarcomas and Ovarian Carcinomas.CompletedNCT03085225Phase 1Results posted
- A Trial of Atezolizumab and Vigil in Patients With Advanced Gynecological CancersCompletedNCT03073525Phase 2Results posted
- IP ALT-803 Followed by SQ ALT-803 for Ovarian CancerCompletedNCT03054909Phase 2Results posted
- A Phase 2 Study of Kevetrin in Subjects With Ovarian CancerCompletedNCT03042702Phase 2Results posted
- IGFBP-2 Vaccine and Combination Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Undergoing SurgeryTerminatedNCT03029611Phase 2Results posted
- Phase II Study of Intraperitoneal NanoPac® in Patients With Ovarian CancerTerminatedNCT03029585Phase 2Results posted
- Durvalumab and Tremelimumab in Treating Participants With Recurrent or Refractory Ovarian, Primary Peritoneal, or Fallopian Tube CancerCompletedNCT03026062Phase 2Results posted
- Olaparib Tablets as a Treatment for Ovarian Cancer Subjects With Different HRD Tumor StatusCompletedNCT02983799Phase 2Results posted
- Folate Receptor Alpha Peptide Vaccine With GM-CSF Versus GM-CSF Alone in Patients With Platinum Sensitive Ovarian CancerTerminatedNCT02978222Phase 2Results posted
- Intraperitoneal Infusion of Autologous Monocytes With Sylatron (Peginterferon Alfa-2b) and Actimmune (Interferon Gamma-1b) in Women With Recurrent or Refractory Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal CancerTerminatedNCT02948426Phase 1Results posted
- A Phase 1/2, Open-Label, Dose-Escalation, Safety Study of INCAGN01949 in Subjects With Advanced or Metastatic Solid TumorsCompletedNCT02923349Phase 1/2Results posted
- Study of Avelumab With or Without Entinostat in Participants With Advanced Epithelial Ovarian CancerCompletedNCT02915523Phase 1/2Results posted
- Phase I Study of Cantrixil in Patients With Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer.CompletedNCT02903771Phase 1Results posted
- Study of Pembrolizumab With or Without CC-486 in Patients With Platinum-resistant Ovarian CancerTerminatedNCT02900560Phase 2Results posted
- Efficacy and Safety Study of Cediranib in Combination With Olaparib in Patients With Recurrent Platinum-Resistant Ovarian CancerCompletedNCT02889900Phase 2Results posted
- A Phase II Study Of Nivolumab/ Bevacizumab/RucaparibActive, not recruitingNCT02873962Phase 2Results posted
- Pembrolizumab Combined With PLD For Recurrent Platinum Resistant Ovarian, Fallopian Tube Or Peritoneal CancerCompletedNCT02865811Phase 2Results posted
- ARIEL4: A Study of Rucaparib Versus Chemotherapy BRCA Mutant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer PatientsCompletedNCT02855944Phase 3Results posted
- Pembrolizumab, Bevacizumab, and Cyclophosphamide in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal CancerCompletedNCT02853318Phase 2Results posted
- Pegylated Liposomal Doxorubicin Hydrochloride With Atezolizumab and/or Bevacizumab in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal CancerActive, not recruitingNCT02839707Phase 2/3Results posted
- Pembrolizumab, Paclitaxel, and Carboplatin in Patients With Advanced Stage Epithelial Ovarian Cancer (EOC).TerminatedNCT02834975Phase 2Results posted
- Non-interventional European Study of Trabectedin + PLD in the Treatment of Relapsed Ovarian Cancer (ROC) PatientsCompletedNCT02825420Results posted
- Expectations and Priorities of Elderly Patients for a First Medical Treatment for CancerCompletedNCT02821793Results posted
- Evaluation of Response to the Neoadjuvant Chemotherapy for Advanced Ovarian Cancer by Multimodal Functional ImagingCompletedNCT02792959Not applicableResults posted
- Phase II: Pembrolizumab/Carboplatin/Taxol in Epithelial Ovary CancerCompletedNCT02766582Phase 2Results posted